PCM Encore’s Eli Lilly LLY Stock Holding History

PCM Encore’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6M	Sell	8,838 -19	-0.2%	-$19.4K	1.86%	10
2026 Q1	$8.15M	Buy	8,857 +402	+5%	+$408K	1.68%	11
2025 Q4	$9.09M	Buy	+8,455	New	+$8.08M	1.93%	9

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM Encore's LLY Position: Q2 2026 in Review

PCM Encore reduced its Eli Lilly (LLY) stake by 0.21% in Q2 2026, selling an estimated $19.4K and leaving 8,838 shares worth $10.6M. The position accounts for 1.86% of the portfolio, ranked #10.

PCM Encore first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

PCM Encore held 8,838 shares of Eli Lilly worth $10.6M as of Q2 2026.
PCM Encore sold 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
Eli Lilly made up 1.86% of PCM Encore's portfolio in Q2 2026, its #10 holding.
PCM Encore first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.